OrsoBio to Present Phase 1 and Preclinical Data for Liver-Targeted Mitochondrial Protonophore TLC-6740 at the American Diabetes Association’s 84th Scientific Sessions

MENLO PARK, Calif.–(BUSINESS WIRE)– #ada2024–OrsoBio shares data on liver-targeted mitochondrial protonophore TLC-6740 at the 84th Scientific Sessions of the American Diabetes Association.
Click here to view original post

Click Here to Publish/Feature Your Company or Product News with Biotech Networks